Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review

Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review

The prevalence of metabolic diseases including type 2 diabetes (T2D), obesity and non-alcoholic fatty liver disease (NAFLD) increases globally. This highlights an unmet need for identifying optimal therapies for the management of these conditions. Tirzepatide is a novel dual incretin receptor agonis...

Full description

Bibliographic Details
Main Authors: Alexandros Leonidas Liarakos, Chrysi Koliaki
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biomedicines
Subjects:
tirzepatide
glucose-dependent insulinotropic polypeptide
glucagon-like peptide 1
dual incretin receptor agonists
twincretins
type 2 diabetes mellitus
Online Access:https://www.mdpi.com/2227-9059/11/7/1875

Internet

https://www.mdpi.com/2227-9059/11/7/1875

Similar Items